PS

Pankaj Singh

Active Director Director DIN 08881974
DIN 08881974 First appointment Sep 2020 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2020
Shareholding value •••• Premium profile

About Pankaj Singh

Data last updated:

Pankaj Singh is a Director at Velenta Pharma Private Limited (since 2020). The company operates in Chemicals. Velenta Pharma Private Limited reported revenue of ₹13.1 Lakh (FY 2025).

DIN 08881974
Primary Designation Director
Industry Chemicals
First Appointment 17 Sep 2020
Oldest Company Age 6 yrs
Largest company Velenta Pharma Private Limited · ₹13.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Velenta Pharma Private Limited U24230UP2020PTC134789
Director17 Sep 20202020₹13.1 Lakh (FY 2025)Active

Board colleagues of Pankaj Singh

Directorship timeline

Open interactive timeline →
Velenta Pharma Private Limited
Premium access

Shareholding and investment profile for Pankaj Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pankaj Singh

Pankaj Singh currently holds 1 directorship: Velenta Pharma Private Limited (Director, since 17 Sep 2020, revenue ₹13.1 Lakh (FY 2025)).

Pankaj Singh was first appointed on 17 Sep 2020 as Director at Velenta Pharma Private Limited.

The current boards of Pankaj Singh's companies include Amit Gupta (Velenta Pharma Private Limited), Amit Mishra (Velenta Pharma Private Limited), Rachit Pandey (Velenta Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available